Release of TGF β from sputum cell culture in COPD and asthma Source: Eur Respir J 2006; 28: Suppl. 50, 673s Year: 2006
Eotaxin-2 in sputum cell culture to evaluate asthma inflammation Source: Eur Respir J 2007; 29: 489-495 Year: 2007
Increased levels of osteopontin in sputum supernatant in patients with COPD Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
Factors associated with sputum culture conversion in patients with pulmonary tuberculosis Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017
Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects Source: International Congress 2019 – Advances in COPD pharmacology Year: 2019
Factors influencing induced sputum cytokines and VEGF in a population of stable COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 550s Year: 2006
Bacterial exacerbation of COPD: assessment of neutrophil activation in induced sputum Source: Annual Congress 2004 - Role of infection in COPD Year: 2004
Predictors of delayed sputum culture conversion in tuberculosis patients Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
Induced sputum: time from expectoration to processing Source: Eur Respir J 2002; 19: 706-708 Year: 2002
Heterogeneous impact of sputum supernatant on neutrophil phagocytosis in bronchiectasis Source: International Congress 2018 – Bronchiectasis: phenotypes, endotypes and new therapies Year: 2018
Increased apoptosis in induced sputum cells in stable COPD Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
Identifying the sputum and BALF cell subpopulation with somatic DNA alterations in COPD Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations Source: Eur Respir J 2006; 27: 483-494 Year: 2006
Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 299s Year: 2005
Sputum culture results of COPD patients with infective attack Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003
Spontaneous sputum production as a marker of bacterial colonisation in stable COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005
Changes in sputum composition during 15 minutes of sputum induction in asthmatic and COPD subjects Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001
Cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010
Sputum cell counts and exacerbations of airway diseases Source: Eur Respir J 2005; 26: Suppl. 49, 485s Year: 2005